Evaluation of a rapid oral fluid point-of-care test for MDMA

Journal of Analytical Toxicology

Volumn 31, Issue 2, 2007, Pages 98-104

  Wilson, Lisa ^a   Jehanli, Ahmed ^a   Hand, Chris ^a   Cooper, Gail ^a   Smith, Robert ^b  

^a Cozart Bioscience Limited ^*  (United Kingdom)

^b SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; METHAMPHETAMINE; N ETHYL 3,4 METHYLENEDIOXYAMPHETAMINE;

ACCURACY; ARTICLE; FLUID INTAKE; GAS CHROMATOGRAPHY; HUMAN; LABORATORY TEST; MASS SPECTROMETRY; POINT OF CARE TESTING; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

EID: 34147120634     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/31.2.98     Document Type: Article

References (20)

1. M. Ramsay, P. Baker, C. Goulden, C. Sharp, and A. Sondhi. Drug misuse declared in 2000: results from the British Crime Survey. Home Office Research Study 224, 2001.
2. Home Office. Updated Drug Strategy 2002, Home Office Drugs Strategy Directorate, 2002.
3. E. Kelly, S. Darke, and J. Ross. A review of drug use and driving: epidemiology, impairment, risk factors and risk perceptions. Drug Alcohol Rev. 23(3): 319-344 (2004).
4. N. Samyn, G. De Boeck, and A.G. Verstraete. The use of oral fluid and sweat wipes for the detection of drugs of abuse in drivers. J. Forensic Sci. 47(6): 1-8 (2002).
5. P. Kintz, V. Cirimele, and B. Ludes. Detection of cannabis in oral fluid (Saliva) and forehead wipes (sweat) from impaired drivers. J. Anal. Toxicol. 24(8): 557-561 (2000).
6. J. Neale and M. Robertson. Comparisons of self-report data and oral fluid testing in detecting drug use amongst new treatment clients. Drug Alcohol Depend. 71: 57-64 (2003).
7. S.W. Toennes, S. Steinmeyer, H. Maurer, M.R. Moeller, and G.F. Kauert. Screening for drugs of abuse in oral fluid - correlation of analysis results with serum in forensic cases. J. Anal. Toxicol. 29(1): 22-27 (2005).
8. C. Barrett, C. Good, and C. Moore. Comparison of point of collection screening of drugs of abuse in oral fluid with a laboratory based urine screen. Forensic Sci. Int. 122: 163-166 (2001).
9. T. Biermann, B. Schwarze, B. Zedler, and P. Betz. On-site testing of illicit drugs: the use of the drug-testing device 'Toxiquick'. Forensic Sci. Int. 143: 21-25 (2004).
10. D.J. Crouch, J.M. Walsh, R. Flegel, L. Cangianelli, J. Baudys, and R. Atkins. An evaluation of selected oral fluid point-of-collection drug-testing devices. J. Anal. Toxicol. 29(4): 244-248 (2005).
11. S. Pichini, M. Navarro, M. Farre, J. Ortuno, P.N. Roset, R. Pacifici, P. Zuccaro, J. Segura, and R. De La Torre. On-site testing of 3,4- methylenedioxymethamphetamine (ecstacy) in saliva with Drug-wipe and Drugread: a controlled study in recreational users. Clin. Chem. 48(1): 174-176 (2002).
12. J.M. Hicks, R. Haeckel, C.P. Price, K. Lewandrowski, and A.H.B. Wu. Recommendations and opinions for the use of point-of-care testing for hospitals and primary care: summary of a 1999 symposium. Clin. Chim. Acta 303: 1-17 (2001).
13. V. Spiehler, D. Baldwin, and C. Hand. Analysis of drugs in saliva. In Forensic Science: On Site Drug Testing, A.J. Jenkins and B.A. Goldberger, Eds. Humana Press, Towota, NJ, 2002, pp 95-109.
14. A. Jehanli, S. Brannan, L. Moore, and V. Spiehler. Blind trials of an opiate saliva drug test for marijuana and opiates. J. Forensic Sci. 46(5): 1214-1420 (2001).
15. L. Moore, J. Wicks, V. Spiehler, and R. Holgate. Gas chromatography-mass spectrometry confirmation of Cozart RapiScan saliva methadone and opiates tests. J. Anal. Toxicol. 25(8): 520-524 (2001).
16. N. De Giovanni, N. Fucci, M. Chiarotti, and S. Scarlata. Cozart® RapiScan System: our experience with saliva tests. J. Chromatogr. B 773: 1-6 (2002).
17. G. Cooper, L. Wilson, C. Reid, L. Main, and C. Hand. Evaluation of the Cozart RapiScan Drug Test System for opiates and cocaine in oral fluid. Forensic Sci. Int. 150: 239-243 (2005).
18. Cozart. Technical information Cozart® RapiScan single panel drug test. Methamphetamine/MDMA version 02/03, 2003.
19. G. Cooper, L. Wilson, C. Reid, C. Hand, and V. Spiehler. Validation of the Cozart Amphetamine Microplate EIA for the analysis of amphetamines in oral fluid. Forensic Sci. Int. 159: 104-112 (2006).
20. P. Akrill. Confirmation analysis of amphetamines in oral fluid by GC-MS method validation report. Internal Cozart Publication, 2006.